Literature DB >> 12036691

Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.

Nahoko Ogata1, Maki Nishikawa, Tetsuya Nishimura, Yumiko Mitsuma, Miyo Matsumura.   

Abstract

PURPOSE: To determine the vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
DESIGN: Prospective, noncomparative case series.
METHODS: Pigment epithelium-derived factor and vascular endothelial growth factor concentrations were measured by enzyme-linked immunosorbent assay in 26 eyes with retinal detachment, 6 with proliferative vitreoretinopathy, and 14 with an idiopathic macular hole.
RESULTS: Pigment epithelium-derived factor concentration in proliferative vitreoretinopathy (0.57 +/- 0.05 microg/ml) was lower (P =.0069), and retinal detachment (2.37 +/- 0.34 microg/ml) was higher (P =.16) than that in macular hole (1.71 +/- 0.22 microg/ml). Vascular endothelial growth factor concentration (168 +/- 139 microg/ml) in proliferative vitreoretinopathy was significantly higher than that in retinal detachment (11 +/- 11 microg/ml, P =.0084) and macular hole (not detectable, P =.0095).
CONCLUSION: Lower levels of pigment epithelium-derived factor and higher levels of vascular endothelial growth factor may be related to ocular cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036691     DOI: 10.1016/s0002-9394(02)01406-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

Review 1.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

2.  Comparison of the effects of intravitreal bevacizumab and dexamethasone in experimental posterior penetrating eye injury.

Authors:  Ayse Oner; Nisa Kahraman; Saim Ozdamar; Esra Balcioglu
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

3.  Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.

Authors:  Sirpa Loukovaara; Kaisa Lehti; Alexandra Robciuc; Timo Pessi; Juha M Holopainen; Katri Koli; Ilkka Immonen; Jorma Keski-Oja
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

4.  Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.

Authors:  K Ghasemi Falavarjani; M Hashemi; M Modarres; A Hadavand Khani
Journal:  Eye (Lond)       Date:  2014-02-21       Impact factor: 3.775

5.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Authors:  M Matsuoka; N Ogata; T Otsuji; T Nishimura; K Takahashi; M Matsumura
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

6.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

7.  Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept.

Authors:  Michael W Stewart
Journal:  Clin Ophthalmol       Date:  2012-07-26

8.  Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study.

Authors:  Lukas J A G Ricker; Aize Kijlstra; Alfons G H Kessels; Wilco de Jager; Albert T A Liem; Fred Hendrikse; Ellen C La Heij
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

9.  Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF.

Authors:  Guo Cheng; Ming Zhong; Riki Kawaguchi; Miki Kassai; Muayyad Al-Ubaidi; Jun Deng; Mariam Ter-Stepanian; Hui Sun
Journal:  Elife       Date:  2014-12-23       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.